Sean Stout, MD
Allergy & Immunology · Boise, IDNPI 1417488131
Payments from drug & device makers
Across 254 payments — averaging $20.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Grifols USA, LLC$682
- GSK$629
- Regeneron Healthcare Solutions, Inc.$418
- Genentech USA, Inc.$255
- CSL Behring$244
- plus $1K from 20 others
What the payments were for
- Consulting fees$341%
- Food & beverage$4,97897%
- Education$1182%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 68 | $1,656 |
| Grifols USA, LLC | 37 | $682 |
| GSK | 45 | $629 |
| Regeneron Healthcare Solutions, Inc. | 20 | $418 |
| Genentech USA, Inc. | 11 | $255 |
| CSL Behring | 12 | $244 |
| Blueprint Medicines Corporation | 10 | $201 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $144 |
| Amgen | 5 | $113 |
| Novartis | 5 | $107 |
| Pharming Healthcare, Inc. | 4 | $80 |
| Optinose US, Inc. | 3 | $52 |
| ADMA Biomanufacturing LLC | 3 | $52 |
| Biocryst US Sales Co., LLC | 2 | $50 |
| Ionis Pharmaceuticals, Inc. | 2 | $44 |
| LEO Pharma Inc. | 2 | $44 |
| Sanofi | 1 | $41 |
| Galderma Laboratories, L.p. | 2 | $33 |
| Pfizer | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Organon | 3 | $23 |
| Sanofi US Services Inc. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $15 |
| Kaleo, Inc. | 1 | $13 |
| Bio Products Laboratory USA, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few allergy & immunology providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 25 | $148,601 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 14 | $78,060 |
| Dupixent PenDupilumab | 18 | $64,405 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 76 | $55,458 |
| TezspireTezepelumab-Ekko | 11 | $50,410 |
| Arnuity ElliptaFluticasone Furoate | 20 | $5,172 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $4,356 |
| Epinephrine | 12 | $3,092 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $2,565 |
| Ipratropium Bromide | 70 | $1,900 |
| Azelastine Hcl | 75 | $1,739 |
| Olopatadine Hcl | 23 | $1,613 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $1,281 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,196 |
| Fluticasone Propionate | 59 | $697 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $244 | $148,60125 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $144 | $78,06014 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta | $629 | $60,63096 claims |
| AstraZenecaTezspire, Symbicort | $1,656 | $54,76628 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy & immunology providers in Idahoon file to place this against a meaningful peer group, so we don't.
Other allergy & immunology in Boise
- John JeppsonBoise$65K
- George PalmerBoise$9K
- Michael KeileyBoise$7K
- Jeremy WaldramBoise$2K
- Wendell PettyIdaho Falls$12K
- Shayne StokesTwin Falls$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.